Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.90
+0.50 (+0.26%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
58
59
Next >
3 Absurdly Cheap Dividend Stocks to Buy and Hold for Years
October 11, 2023
These stocks are potential bargain buys for investors right now, just waiting to get scooped up.
Via
The Motley Fool
The 3 Best Defensive Stocks for Nervous Investors
October 11, 2023
The best defensive stocks are especially worth considering at the moment as volatility spikes and confidence wavers.
Via
InvestorPlace
AbbVie Stock Moves Higher With Rising Relative Strength
October 10, 2023
A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue?
Via
Investor's Business Daily
3 Dividend Kings Every Investor Should Own to Survive a Market Crash
October 10, 2023
Dividend stocks that raise their payout beat all other kinds of stocks, making Dividend Kings the best stocks to buy in a downturn.
Via
InvestorPlace
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
October 09, 2023
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment.
Via
Talk Markets
AbbVie Unusual Options Activity
October 09, 2023
Via
Benzinga
Should You Load Up On This 1 Dividend Stock?
October 06, 2023
It's not that hard a call.
Via
The Motley Fool
Check Out What Whales Are Doing With ABBV
October 03, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About AbbVie
September 29, 2023
Via
Benzinga
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
October 09, 2023
These two healthcare stocks are reliable passive income vehicles.
Via
The Motley Fool
Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream
October 05, 2023
These dividend aristocrats are some of the best options for long-term investors looking to boost their portfolio return.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
7 Top Healthcare Stocks That Pay Dividends
October 04, 2023
With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends.
Via
InvestorPlace
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years
October 04, 2023
These are relatively safe income investments that you can hold on to for the long haul.
Via
The Motley Fool
3 Top Stocks to Buy in October and Hold Forever
October 02, 2023
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.
Via
The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
September 27, 2023
Via
Benzinga
AbbVie Unusual Options Activity
September 26, 2023
Via
Benzinga
How Is The Market Feeling About AbbVie?
September 25, 2023
Via
Benzinga
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
These defensive index funds can help investors hedge against a possible recession.
Via
The Motley Fool
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
September 30, 2023
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.
Via
InvestorPlace
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
These stocks come with great dividends and more.
Via
The Motley Fool
AbbVie's Promising Leap Towards Long-Term Growth: Analyst
September 29, 2023
Raymond James initiated coverage on AbbVie Inc (NYSE: ABBV) as the company looks beyond Humira's loss of exclusivity and has several levers to set up long-term growth.
Via
Benzinga
AbbVie's Leukemia Drug Falls Short In Late-Stage Study In Pretreated Blood Cancer Patients
September 29, 2023
AbbVie Inc (NASDAQ: ABBV) released data from its Phase 3 CANOVA study evaluating venetoclax (Venclexta/ Venclyxto) plus dexamethasone (VenDex) for patients with t(11;14)-positive relapsed or refractory...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
September 29, 2023
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare.
Via
The Motley Fool
Three Of Our Top Picks For Your Healthcare Portfolio
September 26, 2023
Amidst macro uncertainty, healthcare stocks should outperform.
Via
Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
September 26, 2023
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.
Via
InvestorPlace
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
September 21, 2023
Many stocks have nosebleed valuations. But not these.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
September 21, 2023
Dividend Kings are passive income powerhouses, but they aren't always a good value.
Via
The Motley Fool
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.